Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 4
Submit an article Journal homepage
47
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Seventy-Two Hour Continuous Infusion Flavopiridol in Relapsed and Refractory Mantle Cell Lymphoma

Thomas S. Lin Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
,
Orion M. Howard Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
,
Donna S. Neuberg Department of Biostatistics, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
,
Helen H. Kim Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
&
Margaret A. Shipp Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
Pages 793-797 | Published online: 01 Jul 2009

  • Argatoff, L., Connors, J., Klasa, R., Horsman, D. and Gascoyne, R. (1997) "Mantle cell lymphoma: a clinicopathologic study of 80 cases", Blood. 2067-2078.
  • Berger, F., Fetman, P., Sonet, A., Salles, G., Bastion, Y., Bryon, P.A. and Coiffier, B. (1994) "Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with district clinical features and outcome", Blood 83, 2829-2850.
  • Bosch, F., Lopez-Guillermo, A., Campo, E., Ribera, J., Conde, E., Piris, M., Vallespi, T., Woessner, S. and Montserrat, E. (1998) "Mantle cell lymphoma: presenting features, response to therapy, and prognastic factors", Cancer 82, 567-575.
  • Fisher, R., Dahlberg, S., Nathwani, B., Banks, P., Miller, T. and Grogan, T. (1995) "A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study", Blood 85, 1075-1082.
  • Samaha, H., Dumontet, C., Ketterer, N., Moullet, I., Thieblemont, C., Bouafia, F., Callet Bauchu, E., Felman, P., Berger, P., Salles, G., et al. (1998) "Mantle cell lymphoma: a retrospective study of 121 cases", Leukemia 12, 1281-1287.
  • Velders, G., Kulin-Nelemans, J., De Boer, C., Hermans, J., Noordijk, E., Schuuring, E., Kramer, M., Van Deijk, W., Rahder, J., Kluin, P., et al. (1996) "Mantle-cell lymphoma: a population-based clinical study", J. Clin. Oncol. 14, 1269-1274.
  • Weisenburger, D. and Armitage, J. (1996) "Mantle cell lymphoma--an entity comes of age", Blood 87, 4483-4494.
  • Weisenburger, D., Vose, J., Greiner, T., Lynch, J., Chan, W., Bierman, P., Dave, B., Sanger, W. and Armitage, J. (2000) "Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group", Am. J. Hematol. 64, 190-196.
  • Zucca, E., Stein, H. and Coiffier, B. (1994) "European Lymphoma Task Force (ELTF): report of the workshop on mantle cell lymphoma (MCL)", Ann. Oncol. 5, 508-511.
  • Zucca, E. Roggero, E., Pinotti, G., Pedrinis, E. Cappella, C., Venco, A. and Cavalli, F. (1995) "Patterns of survival in mantle cell lymphoma", Ann. Oncol. 6, 257-262.
  • Khouri, I., Lee, M., Romaguera, J., Mirza, N., Kantarjian, H., Korbling, M., Albitar, M., Giralt, S., Samuels, B., Anderlini, P., et al. (1999) "Allogeneic hematopoietic transplantation for mantle cell lymphoma: molecular remissions and evidence of graft-versus-malignancy", Ann. Oncol., 1293-1299.
  • Khouri, I., Romaguera, J., Kantarjian, H., Palmer, J., Pugh, W., Korbling, M., Hagemeister, F., Samuels, B., Rodriguez, A., Giralt, S., et al. (1998) "Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma", J. Clin. Oncol. 16, 3803-3809.
  • Howard, O., Gribben, J., Neuberg, D., Grossbard, M., Kim, H., Poor, C., Janicek, M. and Shipp, M. (2000) "Rituxiinab and CHOP induction therapy for newly diagnosed mantle cell lymphoma: molecular complete responses are not predictive of progression-free survival", J. Clin. Oncol., in press.
  • Decaudin, D., Brousse, N., Brice, P., Haioun, C., Bourhis, J., Morel, P., Van Hoof, A., Souleau, B., Quesnel, B. and Gisselbrecht, C. (2000) "Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study", Bone Marrow Transplant. 25, 251-256.
  • Freedman, A., Neuberg, D., Gribben, J., Mauch, P., Soiffer, R., Fisher, D., Anderson, K., Andersen, N., Schlossman, R., Kroon, M., et al. (1998) "High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission", J. Clin. Oncol. 16, 13-18.
  • Ketterer, N., Salles, G., Espinouse, D., Dumontet, C., Neidbardt-Berard, E., Moullet, I., Bouafia, F., Berger, F, Felman, P and Coiffier, B (1997) "Intensive therapy with peripheral stein cell transplantation in 16 patients with mantle cell lymphoma", Ann Oncol. 8, 701-704.
  • Milpied, N., Gaillard, F. Moreau, P., Mahe, B., Souchet, J., Rapp, M., Bulabois, C., Morineau, N. and Harousseau, J. (1998) "High dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience", Bone Marrow Transplant. 22, 645-650.
  • Vose, J., Bierman, P., Weisenburger, D., Lynch, J., Bociek, Y., Chan, W., Greiner, T. and Armitage, I/ (2000) "Autologous hematopoietic stem cell transplantation for mantle cell lymphoma", Biol. Blood Marrow Transplant. 6, 640-645.
  • Leroux, D., LeMarc'Hadour, F., Gressin, R., Jacob, M., Keddari, E., Monteil, M, Caillot, P., Jalbert, P. and Scotto, J. (1991) "Non-Hodgkin's lymphomas with t(11;14)(q13:q32): a subset of mantle zone/intermediate lymphocytic lymphoma?", Br. J. Haematol. 77, 346-353.
  • Vanderberghe, E., DeWolf Peeters, C., Wlodarska, I., Stul, M., Louwagie, A., Verhoef, G., Thomas, J., Criel, A., Cassiman, J. and Mecucci, C. (1992) "Chromosome 11q rearrangements in B non-Hodgkin's lymphoma", Br. J. Haematol. 81, 212-217.
  • Weisenburger, D., Linder, J., Daley, H. and Armitage, J. (1987) "Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas", Hum. Pathol. 18, 781-790.
  • Sausville, E., Johnson, J., Alley, M., Zaharevitz, D. and Senderowicz, A. (2000) "Inhibition of CDKs as a therapeutic modality", Ann. NY Acad. Sci. 910, 207-222.
  • Senderowicz, A. and Sausville, E. (2000) "Preclinical and clinical development of cyclin-dependent kinase modulators", J. Natl Lancer Inst. 92, 376-387.
  • Carlson, B., Dubay, M., Sausville, E., Brizuela, L. and Worland, P. (1996) "Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells", Cancer Res. 56, 2973-2978.
  • Carlson, B., Lahusen, T., Singh, S., Loaiza-Perez, A., Worland, P., Pestell, R., Albanese, C., Sausville, E. and Senderowicz, A. (1999) "Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol", Cancer Res. 59, 4634-4641.
  • Kaur, G., Stetler-Stevenson, M., Sehers, S., Worland, P., Sedlacek, H., Myers, C. Czech, J., Naik, R. and Sausville, K. (1992) "Growth inhibition with reversible cell cycle arrest carcinoma cells by flavone", J. Null. Cancer Inst. 84, 1736-1740.
  • Parker, B., Kaur, G., Nieves-Neira, W., Taimi, M., Kohlhagen, G., Shimizu, T., Losiewicz, M., Pommier, Y., Sausville, E. and Senderowicz, A. (1998) "Early induction of apoptasis in hematopoietic cell lines after exposure to flavopiridol", Blind 91, 458-465.
  • Senderowicz, A., Headlee, D., Stinson, S., Lush, R., Kalil, N., Villalba, L., Hill, K., Steinberg, S., Figg, W., Tompkins, A., Aibuck, S.G. and Sausville, E.A. (1998) "Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms", J. Clin. Oncol. 16, 2986-2999.
  • Schwartz, G., Ilson, D., Saltz, U. O'Reilly, E., Tong, W., Maslak, P. Werner, J., Perkins, P., Stoltz, M. and Kelsen, D. (2001) "Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma", J. Clin. Oncol. 19, 1985-1992.
  • Shapiro, G., Supko, J., Patterson, A., Lynch, C., Lucca, J., Zacarola, P., Muzikansky, A., Wright, J., Lynch, T. and Rollins, B (2001) "A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer", Clin. Cancer Res. 7, 1590-1599.
  • Stadler, W., Vogelzang, N., Amato, R., Sosman, J., Taber, D., Liebowitz, D. and Yokes, E. (2000) "Flavopiridol, a novel cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non small cell lung cancer", J. Clin. Oncol 18, 371-375.
  • Innocenti, F., Stadler, W., Iyer, L., Rameriz, J., Vokes, E. and Ratain, M. (2000) "Havopiridol metabolism in cancer patients is associated with the occurrence of diarrhea", Clin. Cancer Res. 6, 3400-3405.
  • Shinn, C., Larsen, D., Suarez, J., Buj, V., Petric, R., Pearson., M. Flinn, I., Levasseur, L., Greaver, M. and Byrd, J. (2000) "Flavopiridol sensitivity of chronic lymphocytic leukemia (CLL) cells in vitro varies based upon species drug protein binding", Blood 96, 294b.
  • Bible, K. and Kaufmann, S. (1997) "Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration", Cancer Res 57, 3375-3380.
  • Motwani, M., Delohery, T. and Schwartz, G. (1999) "Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-Created human gastric and breast cancer cells", Clin. Cancer Res. 5, 1876-1883.
  • Bunch, R. and Eastman, A. (1997) "7-Hydroxystauroosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells", Cell Growth Differ. 8, 779-788.
  • Yu, L., Ortandi, L., Wang, P., Orr, M., Senderowicz, A., Sausville, E., Silvestrini, R., Watanabe, N., Piwnica-Worms, H. and O'Connor, P. (1998) "UCN-01 abrogates G2 arrest through a cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the cdc25c phosphatase", J. Biol. Chem. 273, 33455-33464.
  • Monks, A., Harris, E., Vaigro-Wolff, A., Hose, C., Connelly, J. and Sausville, C. (2000) "UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines", lnvest. New Drugs 18, 95-107.
  • Bunch, R. and Eastman, A. (1996) "Enhancement ot cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (LCN-01), a new 02 checkpoint inhibitor", Clin. Cancer Res. 2, 791-797.
  • Tsuhida, E. and Urano, M. (1997) "The effect of UCN-01(7-hydroxystaurosporine). a potent inhibitor of protein kinase C. on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma", Int. J. Radiat. Oncol. Biol. Phys. 39, 1153-1161.
  • Sausville, E., Arbuck, S., Messman, R., Headlee, D., Bauer, K., Lush, R., Murgo, A., Figg, W., Lahusen, T., Jaken, S., et al. (2001) "Phase 1 trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms", J Clin Oncol. 19, 2319-2333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.